These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 32382848)

  • 1. Prevalence and correlates of hyperkalemia in a renal nutrition clinic.
    D'Alessandro C; Cumetti A; Pardini E; Mannucci C; Serio P; Morganti R; Cupisti A
    Intern Emerg Med; 2021 Jan; 16(1):125-132. PubMed ID: 32382848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of hyperkalemia with clinical outcomes in advanced chronic kidney disease.
    Caravaca-Fontán F; Valladares J; Díaz-Campillejo R; Barroso S; Luna E; Caravaca F
    Nefrologia (Engl Ed); 2019; 39(5):513-522. PubMed ID: 31027897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of hyperkalemia and RAASi nonadherence on patients affected by heart failure or chronic kidney disease].
    Degli Esposti L; Perrone V; Giacomini E; Sangiorgi D; Alessandrini D; Santoro A
    G Ital Nefrol; 2019 Sep; 36(5):. PubMed ID: 31580544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal potassium handling in chronic kidney disease: Differences between patients with or wihtout hyperkalemia.
    Caravaca-Fontán F; Valladares J; Díaz-Campillejo R; Barroso S; Luna E; Caravaca F
    Nefrologia (Engl Ed); 2020; 40(2):152-159. PubMed ID: 31353054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and Efficacy of Patiromer in Hyperkalemic Patients with CKD: A Pooled Analysis of Three Randomized Trials.
    Haller H; Bianchi S; McCafferty K; Arthur S; Quinn CM; Budden J; Weir MR
    Kidney360; 2022 Dec; 3(12):2019-2026. PubMed ID: 36591361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum potassium in stage 5 CKD patients on their first presentation in a dialysis service of a county hospital in western Romania.
    Gluhovschi G; Mateş A; Gluhovschi C; Golea O; Gădălean F; Somai M; Ene I; Petrica L; Velciov S
    Rom J Intern Med; 2014; 52(1):30-8. PubMed ID: 25000676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current Management of Hyperkalemia in Non-Dialysis CKD: Longitudinal Study of Patients Receiving Stable Nephrology Care.
    Borrelli S; De Nicola L; Minutolo R; Conte G; Chiodini P; Cupisti A; Santoro D; Calabrese V; Giannese D; Garofalo C; Provenzano M; Bellizzi V; Apicella L; Piccoli GB; Torreggiani M; Di Iorio BR
    Nutrients; 2021 Mar; 13(3):. PubMed ID: 33804015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prevalence of predialysis hyperkalemia and associated characteristics among hemodialysis patients: The RE-UTILIZE study.
    Agiro A; Duling I; Eudicone J; Davis J; Brahmbhatt YG; Cooper K
    Hemodial Int; 2022 Jul; 26(3):397-407. PubMed ID: 35037388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correction of hyperkalemia in dogs with chronic kidney disease consuming commercial renal therapeutic diets by a potassium-reduced home-prepared diet.
    Segev G; Fascetti AJ; Weeth LP; Cowgill LD
    J Vet Intern Med; 2010; 24(3):546-50. PubMed ID: 20337915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated potassium levels in patients with chronic kidney disease: occurrence, risk factors and clinical outcomes-a Danish population-based cohort study.
    Thomsen RW; Nicolaisen SK; Hasvold P; Sanchez RG; Pedersen L; Adelborg K; Egstrup K; Egfjord M; Sørensen HT
    Nephrol Dial Transplant; 2018 Sep; 33(9):1610-1620. PubMed ID: 29177463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-analysis of persistent hyperkalaemia in non-dialysis chronic kidney disease patients under nephrology care in Italy.
    Provenzano M; De Francesco M; Iannazzo S; Garofalo C; Andreucci M; Genualdo R; Borrelli S; Minutolo R; Conte G; De Nicola L
    Int J Clin Pract; 2020 May; 74(5):e13475. PubMed ID: 31909866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of patiromer in the treatment of hyperkalemia in chronic kidney disease patients with hypertension on diuretics.
    Weir MR; Mayo MR; Garza D; Arthur SA; Berman L; Bushinsky D; Wilson DJ; Epstein M
    J Hypertens; 2017 May; 35 Suppl 1(Suppl 1):S57-S63. PubMed ID: 28129247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and clinical correlates of hyperkalemia in stable kidney transplant recipients.
    Bussalino E; Panaro L; Marsano L; Bellino D; Ravera M; Paoletti E
    Intern Emerg Med; 2021 Oct; 16(7):1787-1792. PubMed ID: 33544373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The frequency of hyperkalemia and its significance in chronic kidney disease.
    Einhorn LM; Zhan M; Hsu VD; Walker LD; Moen MF; Seliger SL; Weir MR; Fink JC
    Arch Intern Med; 2009 Jun; 169(12):1156-62. PubMed ID: 19546417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between Serum Potassium and Outcomes in Patients with Reduced Kidney Function.
    Luo J; Brunelli SM; Jensen DE; Yang A
    Clin J Am Soc Nephrol; 2016 Jan; 11(1):90-100. PubMed ID: 26500246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Patiromer on Hyperkalemia Recurrence in Older Chronic Kidney Disease Patients Taking RAAS Inhibitors.
    Weir MR; Bushinsky DA; Benton WW; Woods SD; Mayo MR; Arthur SP; Pitt B; Bakris GL
    Am J Med; 2018 May; 131(5):555-564.e3. PubMed ID: 29180023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Patiromer in Hyperkalemic Patients Taking and Not Taking RAAS Inhibitors.
    Kloner RA; Gross C; Yuan J; Conrad A; Pergola PE
    J Cardiovasc Pharmacol Ther; 2018 Nov; 23(6):524-531. PubMed ID: 30103622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum potassium and outcomes in CKD: insights from the RRI-CKD cohort study.
    Korgaonkar S; Tilea A; Gillespie BW; Kiser M; Eisele G; Finkelstein F; Kotanko P; Pitt B; Saran R
    Clin J Am Soc Nephrol; 2010 May; 5(5):762-9. PubMed ID: 20203167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of hyperkalemia and long inter-dialytic interval on morbidity and mortality in patients receiving hemodialysis: a systematic review.
    Bem D; Sugrue D; Wilding B; Zile I; Butler K; Booth D; Tafesse E; McEwan P
    Ren Fail; 2021 Dec; 43(1):241-254. PubMed ID: 33478329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of hyperkalemia among hemodialysis patients in Egypt.
    Khedr E; Abdelwhab S; El-Sharkawy M; Ali M; El Said K
    Ren Fail; 2009; 31(10):891-8. PubMed ID: 20030523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.